Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v7-FR
Language French French
Date Updated 2017-09-13 2017-09-13
Drug Identification Number 02238675 02238675
Brand name INTRON A INTRON A
Common or Proper name interferon alfa-2b solution for injection interferon alfa-2b solution for injection
Company Name MERCK CANADA INC MERCK CANADA INC
Ingredients INTERFERON ALFA-2B INTERFERON ALFA-2B
Strength(s) 10000000UNIT 10000000UNIT
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 1X25MIU HSA FREE VIAL 1X25MIU HSA FREE VIAL
ATC code L03AB L03AB
ATC description IMMUNOSTIMULANTS IMMUNOSTIMULANTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2017-08-14 2017-08-14
Estimated end date 2017-09-15 2017-09-15
Actual end date 2017-09-12 2017-09-12
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Limited Quantities available / Quantités limitées disponibles Limited Quantities available / Quantités limitées disponibles
Health Canada comments